Improving Clinic Capacity with Faricimab

Clinic capacity constraints are an ever-increasing problem in ophthalmology. Multiple case studies demonstrate that faricimab frees up clinic capacity with extended treatment intervals in both treatment-naïve and treatment-experienced patients. In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient with faricimab resulted in several benefits, including timely treatment, reduced treatment burden for patients and caregivers, reduced frequency and cost of out-of-hours services, and freed up clinic staff to manage waiting lists in other ophthalmology services. Ultimately, these outcomes highlight that the introduction of faricimab is cost-effective, leading to better quality of care, the potential for better patient adherence, and less overtime and burnout for clinic staff.